These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Herbal and polymeric approaches for liver-targeting drug delivery: novel strategies and their significance. Rohilla R; Garg T; Goyal AK; Rath G Drug Deliv; 2016 Jun; 23(5):1645-61. PubMed ID: 25101832 [TBL] [Abstract][Full Text] [Related]
4. Nanoparticles for human liver-specific drug and gene delivery systems: in vitro and in vivo advances. Kasuya T; Kuroda S Expert Opin Drug Deliv; 2009 Jan; 6(1):39-52. PubMed ID: 19236207 [TBL] [Abstract][Full Text] [Related]
5. Advantages and challenges in nanomedicines for chronic liver diseases: A hepatologist's perspectives. Ezhilarasan D Eur J Pharmacol; 2021 Feb; 893():173832. PubMed ID: 33359144 [TBL] [Abstract][Full Text] [Related]
6. New gene therapy strategies for hepatic fibrosis. Salazar-Montes AM; Hernández-Ortega LD; Lucano-Landeros MS; Armendariz-Borunda J World J Gastroenterol; 2015 Apr; 21(13):3813-25. PubMed ID: 25852266 [TBL] [Abstract][Full Text] [Related]
8. Polymers for siRNA delivery: inspired by viruses to be targeted, dynamic, and precise. Wagner E Acc Chem Res; 2012 Jul; 45(7):1005-13. PubMed ID: 22191535 [TBL] [Abstract][Full Text] [Related]
9. Construction of a star-shaped copolymer as a vector for FGF receptor-mediated gene delivery in vitro and in vivo. Li D; Ping Y; Xu F; Yu H; Pan H; Huang H; Wang Q; Tang G; Li J Biomacromolecules; 2010 Sep; 11(9):2221-9. PubMed ID: 20704346 [TBL] [Abstract][Full Text] [Related]
10. Design of a temporally and spatially controlled drug delivery system for the treatment of liver diseases in mice. Shibuya I; Akaike T; Watanabe Y Hepatology; 2000 Dec; 32(6):1300-8. PubMed ID: 11093737 [TBL] [Abstract][Full Text] [Related]
11. Efficient gene delivery and targeted expression to hepatocytes in vivo by improved lentiviral vectors. Follenzi A; Sabatino G; Lombardo A; Boccaccio C; Naldini L Hum Gene Ther; 2002 Jan; 13(2):243-60. PubMed ID: 11812281 [TBL] [Abstract][Full Text] [Related]
12. In vivo hepatic gene therapy. Ni YH Acta Paediatr Taiwan; 2001; 42(4):191-200. PubMed ID: 11550406 [TBL] [Abstract][Full Text] [Related]
13. The use of nanoparticles to deliver nitric oxide to hepatic stellate cells for treating liver fibrosis and portal hypertension. Duong HT; Dong Z; Su L; Boyer C; George J; Davis TP; Wang J Small; 2015 May; 11(19):2291-304. PubMed ID: 25641921 [TBL] [Abstract][Full Text] [Related]
14. Drug targeting to the diseased liver. Poelstra K; Prakash J; Beljaars L J Control Release; 2012 Jul; 161(2):188-97. PubMed ID: 22370583 [TBL] [Abstract][Full Text] [Related]
15. Targeted polymers for gene delivery. Hughes JA; Rao GA Expert Opin Drug Deliv; 2005 Jan; 2(1):145-57. PubMed ID: 16296741 [TBL] [Abstract][Full Text] [Related]
16. Properties, engineering and applications of lipid-based nanoparticle drug-delivery systems: current research and advances. Buse J; El-Aneed A Nanomedicine (Lond); 2010 Oct; 5(8):1237-60. PubMed ID: 21039200 [TBL] [Abstract][Full Text] [Related]